{"entity":{"type":"insider","cik":"0001575745","url":"/insider/0001575745","json_url":"/insider/0001575745.json","name":"Jovan-Embiricos Morana","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":74,"n_filings":16,"first":"2014-06-13","last":"2022-08-04","span_basis":"filed_date"},"name_variants":[{"name":"Jovan-Embiricos Morana","source":"filing","n_filings":16,"first_seen":"2014-06-13","last_seen":"2022-08-04"}],"transactions":[{"id":6322858,"accession":"0001104659-22-086343","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-086343","line_url":"/filing/0001104659-22-086343#line-3","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 Vision SCS; Jovan-Embiricos Morana","owner_display_name":"F2 Vision SCS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25989.0,"shares_display":"25,989","price_per_share":14.3056,"price_display":"14.31","price_state":"stated","total_value":371788.2384,"total_display":"371,788.24","total_whole":"371,788","shares_owned_after":1255963.0,"shares_owned_after_display":"1,255,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-04","filed_date":"2022-08-04","scope":"insider"},{"id":6322856,"accession":"0001104659-22-086343","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-086343","line_url":"/filing/0001104659-22-086343#line-2","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 Vision SCS; Jovan-Embiricos Morana","owner_display_name":"F2 Vision SCS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19129.0,"shares_display":"19,129","price_per_share":14.2367,"price_display":"14.24","price_state":"stated","total_value":272333.8343,"total_display":"272,333.83","total_whole":"272,334","shares_owned_after":1281952.0,"shares_owned_after_display":"1,281,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-04","scope":"insider"},{"id":6322854,"accession":"0001104659-22-086343","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-086343","line_url":"/filing/0001104659-22-086343#line-1","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 Vision SCS; Jovan-Embiricos Morana","owner_display_name":"F2 Vision SCS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4792.0,"shares_display":"4,792","price_per_share":14.0973,"price_display":"14.10","price_state":"stated","total_value":67554.2616,"total_display":"67,554.26","total_whole":"67,554","shares_owned_after":1301081.0,"shares_owned_after_display":"1,301,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-04","scope":"insider"},{"id":6927765,"accession":"0001104659-22-073980","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-073980","line_url":"/filing/0001104659-22-073980#line-3","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Jovan-Embiricos Morana; F2 Bioscience I 2017 Ltd","owner_display_name":"Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29631.0,"shares_display":"29,631","price_per_share":13.0036,"price_display":"13.00","price_state":"stated","total_value":385309.6716,"total_display":"385,309.67","total_whole":"385,310","shares_owned_after":537392.0,"shares_owned_after_display":"537,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-23","filed_date":"2022-06-23","scope":"insider"},{"id":6927762,"accession":"0001104659-22-073980","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-073980","line_url":"/filing/0001104659-22-073980#line-2","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Jovan-Embiricos Morana; F2 Bioscience I 2017 Ltd","owner_display_name":"Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49953.0,"shares_display":"49,953","price_per_share":12.7035,"price_display":"12.70","price_state":"stated","total_value":634577.9355,"total_display":"634,577.94","total_whole":"634,578","shares_owned_after":567023.0,"shares_owned_after_display":"567,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-22","filed_date":"2022-06-23","scope":"insider"},{"id":6927758,"accession":"0001104659-22-073980","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-073980","line_url":"/filing/0001104659-22-073980#line-1","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Jovan-Embiricos Morana; F2 Bioscience I 2017 Ltd","owner_display_name":"Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22319.0,"shares_display":"22,319","price_per_share":12.7662,"price_display":"12.77","price_state":"stated","total_value":284928.8178,"total_display":"284,928.82","total_whole":"284,929","shares_owned_after":616976.0,"shares_owned_after_display":"616,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-21","filed_date":"2022-06-23","scope":"insider"},{"id":6569172,"accession":"0001104659-22-061591","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-22-061591","line_url":"/filing/0001104659-22-061591#line-4","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Jovan-Embiricos Morana; F2 Vision SCS","owner_display_name":"Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35158.0,"shares_display":"35,158","price_per_share":11.2301,"price_display":"11.23","price_state":"stated","total_value":394827.8558,"total_display":"394,827.86","total_whole":"394,828","shares_owned_after":1305873.0,"shares_owned_after_display":"1,305,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-16","scope":"insider"},{"id":6569169,"accession":"0001104659-22-061591","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-061591","line_url":"/filing/0001104659-22-061591","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Jovan-Embiricos Morana; F2 Vision SCS","owner_display_name":"Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":119508.0,"shares_display":"119,508","price_per_share":10.111261487933863,"price_display":"10.11","price_state":"stated","total_value":1208376.6379,"total_display":"1,208,376.64","total_whole":"1,208,377","shares_owned_after":1375220.0,"shares_owned_after_display":"1,375,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-13","filed_date":"2022-05-16","scope":"insider","n_lines":2},{"id":6569163,"accession":"0001104659-22-061591","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-061591","line_url":"/filing/0001104659-22-061591#line-1","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Jovan-Embiricos Morana; F2 Vision SCS","owner_display_name":"Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":264072.0,"shares_display":"264,072","price_per_share":9.2497,"price_display":"9.25","price_state":"stated","total_value":2442586.7784,"total_display":"2,442,586.78","total_whole":"2,442,587","shares_owned_after":1460539.0,"shares_owned_after_display":"1,460,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-16","scope":"insider"},{"id":4164078,"accession":"0000899243-21-044619","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-044619","line_url":"/filing/0000899243-21-044619","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":"0001575745","owner_name":"Jovan-Embiricos Morana","owner_display_name":"Jovan-Embiricos Morana","owner_url":"/insider/0001575745","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":24.765,"price_display":"24.76","price_state":"stated","total_value":19812.0,"total_display":"19,812.00","total_whole":"19,812","shares_owned_after":1375262.0,"shares_owned_after_display":"1,375,262","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-15","scope":"insider","n_lines":2},{"id":4205545,"accession":"0000899243-21-043670","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-043670","line_url":"/filing/0000899243-21-043670","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":"0001575745","owner_name":"Jovan-Embiricos Morana","owner_display_name":"Jovan-Embiricos Morana","owner_url":"/insider/0001575745","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3815.0,"shares_display":"3,815","price_per_share":24.7882,"price_display":"24.79","price_state":"stated","total_value":94566.983,"total_display":"94,566.98","total_whole":"94,567","shares_owned_after":1375942.0,"shares_owned_after_display":"1,375,942","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-09","filed_date":"2021-11-09","scope":"insider","n_lines":2},{"id":4205538,"accession":"0000899243-21-043670","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-043670","line_url":"/filing/0000899243-21-043670","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":"0001575745","owner_name":"Jovan-Embiricos Morana","owner_display_name":"Jovan-Embiricos Morana","owner_url":"/insider/0001575745","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8381.0,"shares_display":"8,381","price_per_share":24.8047,"price_display":"24.80","price_state":"stated","total_value":207888.1907,"total_display":"207,888.19","total_whole":"207,888","shares_owned_after":1379185.0,"shares_owned_after_display":"1,379,185","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-05","filed_date":"2021-11-09","scope":"insider","n_lines":2},{"id":5328647,"accession":"0000899243-21-042033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-042033","line_url":"/filing/0000899243-21-042033","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":"0001575745","owner_name":"Jovan-Embiricos Morana","owner_display_name":"Jovan-Embiricos Morana","owner_url":"/insider/0001575745","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":24.7775,"price_display":"24.78","price_state":"stated","total_value":54510.5,"total_display":"54,510.50","total_whole":"54,511","shares_owned_after":1386309.0,"shares_owned_after_display":"1,386,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-27","filed_date":"2021-10-29","scope":"insider","n_lines":2},{"id":4357426,"accession":"0000899243-21-041467","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-041467","line_url":"/filing/0000899243-21-041467","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":"0001575745","owner_name":"Jovan-Embiricos Morana","owner_display_name":"Jovan-Embiricos Morana","owner_url":"/insider/0001575745","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7769.0,"shares_display":"7,769","price_per_share":24.8183,"price_display":"24.82","price_state":"stated","total_value":192813.3727,"total_display":"192,813.37","total_whole":"192,813","shares_owned_after":1388179.0,"shares_owned_after_display":"1,388,179","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-25","filed_date":"2021-10-25","scope":"insider","n_lines":2},{"id":4357419,"accession":"0000899243-21-041467","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-041467","line_url":"/filing/0000899243-21-041467","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":"0001575745","owner_name":"Jovan-Embiricos Morana","owner_display_name":"Jovan-Embiricos Morana","owner_url":"/insider/0001575745","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5723.0,"shares_display":"5,723","price_per_share":24.7697,"price_display":"24.77","price_state":"stated","total_value":141756.9931,"total_display":"141,756.99","total_whole":"141,757","shares_owned_after":1394783.0,"shares_owned_after_display":"1,394,783","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-22","filed_date":"2021-10-25","scope":"insider","n_lines":2},{"id":4357412,"accession":"0000899243-21-041467","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-041467","line_url":"/filing/0000899243-21-041467","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":"0001575745","owner_name":"Jovan-Embiricos Morana","owner_display_name":"Jovan-Embiricos Morana","owner_url":"/insider/0001575745","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":24.75,"price_display":"24.75","price_state":"stated","total_value":2475.0,"total_display":"2,475.00","total_whole":"2,475","shares_owned_after":1399647.0,"shares_owned_after_display":"1,399,647","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-21","filed_date":"2021-10-25","scope":"insider","n_lines":2},{"id":4083654,"accession":"0000899243-21-002048","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-21-002048","line_url":"/filing/0000899243-21-002048","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Management, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 - TPO Investments LLC; Jovan-Embiricos Morana; F2 MG Ltd; Globeways Holdings Ltd; F2 Bioscience I 2017 Ltd; F2 MC, LLC; F2 Bio TD, LLC; F2 Vision SCS; F2 GC, LLC","owner_display_name":"F2 - TPO Investments LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":4200000.0,"total_display":"4,200,000.00","total_whole":"4,200,000","shares_owned_after":104762.0,"shares_owned_after_display":"104,762","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-14","scope":"insider","n_lines":2},{"id":2101217,"accession":"0000899243-20-021597","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-021597","line_url":"/filing/0000899243-20-021597","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":"0001575745","owner_name":"Jovan-Embiricos Morana","owner_display_name":"Jovan-Embiricos Morana","owner_url":"/insider/0001575745","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2900000.0,"shares_display":"2,900,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":49300000.0,"total_display":"49,300,000.00","total_whole":"49,300,000","shares_owned_after":2800000.0,"shares_owned_after_display":"2,800,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-06","scope":"insider","n_lines":2},{"id":8725355,"accession":"0000899243-19-029791","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-029791","line_url":"/filing/0000899243-19-029791","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 - TPO Investments LLC; F2 Capital I 2019, LLC; F2 BBG LLC; Jovan-Embiricos Morana; F2 MG Ltd; Globeways Holdings II Ltd; F2 Capital I 2015 Ltd; Globeways Holdings Ltd; F2 Captial I 2017 Ltd; F2 Bioscience II 2017 Ltd","owner_display_name":"F2 - TPO Investments LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41965.0,"shares_display":"41,965","price_per_share":16.4714,"price_display":"16.47","price_state":"stated","total_value":691222.301,"total_display":"691,222.30","total_whole":"691,222","shares_owned_after":155986.0,"shares_owned_after_display":"155,986","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-19","filed_date":"2019-12-20","scope":"insider","n_lines":2},{"id":8725350,"accession":"0000899243-19-029791","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-029791","line_url":"/filing/0000899243-19-029791","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 - TPO Investments LLC; F2 Capital I 2019, LLC; F2 BBG LLC; Jovan-Embiricos Morana; F2 MG Ltd; Globeways Holdings II Ltd; F2 Capital I 2015 Ltd; Globeways Holdings Ltd; F2 Captial I 2017 Ltd; F2 Bioscience II 2017 Ltd","owner_display_name":"F2 - TPO Investments LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2891.0,"shares_display":"2,891","price_per_share":17.006,"price_display":"17.01","price_state":"stated","total_value":49164.346,"total_display":"49,164.35","total_whole":"49,164","shares_owned_after":191309.0,"shares_owned_after_display":"191,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-20","scope":"insider","n_lines":2},{"id":7886918,"accession":"0000899243-19-028968","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_display_name":"Globeways Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7743.0,"shares_display":"7,743","price_per_share":17.6525,"price_display":"17.65","price_state":"stated","total_value":136683.3075,"total_display":"136,683.31","total_whole":"136,683","shares_owned_after":1299876.0,"shares_owned_after_display":"1,299,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-11","scope":"insider","n_lines":4},{"id":7886902,"accession":"0000899243-19-028968","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_display_name":"Globeways Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56830.0,"shares_display":"56,830","price_per_share":17.6232,"price_display":"17.62","price_state":"stated","total_value":1001526.456,"total_display":"1,001,526.46","total_whole":"1,001,526","shares_owned_after":1304029.0,"shares_owned_after_display":"1,304,029","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider","n_lines":4},{"id":7886888,"accession":"0000899243-19-028968","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_display_name":"Globeways Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139989.0,"shares_display":"139,989","price_per_share":17.6511,"price_display":"17.65","price_state":"stated","total_value":2470959.8379,"total_display":"2,470,959.84","total_whole":"2,470,960","shares_owned_after":1334504.0,"shares_owned_after_display":"1,334,504","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider","n_lines":4},{"id":8580892,"accession":"0000899243-19-025909","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-025909","line_url":"/filing/0000899243-19-025909","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 MG Ltd; Jovan-Embiricos Morana; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings Ltd; Globeways Holdings II Ltd; F2 - TPO Investments LLC","owner_display_name":"F2 MG Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3888.0,"shares_display":"3,888","price_per_share":15.1571,"price_display":"15.16","price_state":"stated","total_value":58930.8048,"total_display":"58,930.80","total_whole":"58,931","shares_owned_after":1409571.0,"shares_owned_after_display":"1,409,571","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-22","filed_date":"2019-10-24","scope":"insider","n_lines":4},{"id":8197830,"accession":"0000899243-19-024208","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-12","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_display_name":"Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5516.0,"shares_display":"5,516","price_per_share":17.3114,"price_display":"17.31","price_state":"stated","total_value":95489.6824,"total_display":"95,489.68","total_whole":"95,490","shares_owned_after":1411656.0,"shares_owned_after_display":"1,411,656","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-24","scope":"insider"},{"id":8197826,"accession":"0000899243-19-024208","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-11","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_display_name":"Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1835.0,"shares_display":"1,835","price_per_share":17.3114,"price_display":"17.31","price_state":"stated","total_value":31766.419,"total_display":"31,766.42","total_whole":"31,766","shares_owned_after":469464.0,"shares_owned_after_display":"469,464","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-24","scope":"insider"}],"collapsed":true,"next_cursor":"2019-09-23|8197826","ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001789972","name":"Cullinan Oncology, Inc.","url":"/issuer/0001789972","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2021-01-14","last_seen":"2022-08-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001754068","name":"Allovir, Inc.","url":"/issuer/0001754068","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2020-08-06","last_seen":"2021-11-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001750019","name":"TCR2 THERAPEUTICS INC.","url":"/issuer/0001750019","role":"Director, Ten percent owner","n_filings":6,"first_seen":"2019-02-21","last_seen":"2019-12-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001428522","name":"Radius Health, Inc.","url":"/issuer/0001428522","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2014-06-13","last_seen":"2014-06-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001575745","retrieved_at":"2026-08-25T04:11:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}